Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
|Videos|September 30, 2021
What keeps you up at night in ophthalmology: Part VI
Ophthalmologists and industry executives share what lingers on their minds at the end of the day.
Advertisement
Featured in this video, in order of appearance:
Jag Dosanjh; senior vice president, Eye Care (Allergan, an AbbVie company)
Mitch Shultz, MD; Shultz Chang Vision (Northridge, CA)
Yolande Barnard; vice president, general manager, U.S. Pharmaceuticals (Bausch + Lomb)
Eric Donnenfeld, MD; Ophthalmic Consultants of Long Island (Garden City, NY)
Edward Manche, MD; Stanford University School of Medicine (Palo Alto, CA)
Watch the previous installments in this series:
Advertisement
Related to this article
Dry eye cases rise with heavy screen use and younger patients; learn modern workups spotlighting MGD, etiology-driven treatments, and collaborative care reshaping outcomes.
Andrew G. Lee, MD, and Drew Carey, MD, discuss findings from a retrospective study examining ischemic stroke risk in patients with non-arteritic anterior ischemic optic neuropathy and the implications for vascular risk factor management.
Optometrist–ophthalmologist co-management targets dry eye early, improves cataract and refractive surgery satisfaction, and uses advanced diagnostics and treatments for healthier ocular surfaces.
Diana Canto-Sims, OD, owner of Buena Vista Optical, discusses how Meta's donation of free AI glasses to blind veterans could close longstanding access gaps in low vision care—and where voice-command wearables fit alongside traditional rehabilitation tools.
Their conversation covers a holistic, cross-specialty approach to ocular surface disease and the unmet need driving a new model of dry eye care in Ireland.
Douglas D. Koch, MD, and Karolinne Maia Rocha, MD, PhD, discuss the optics behind enhanced monofocal lenses, patient selection, and how to set expectations.
Advertisement
Advertisement